NCT06052852 2025-11-17Study of BDC-3042 as Single Agent and in Combination With Cemiplimab in Patients With Advanced MalignanciesBolt Biotherapeutics, Inc.Phase 1 Terminated17 enrolled
NCT04954599 2025-10-07Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICIMaastricht University Medical CenterPhase 1/2 Recruiting126 enrolled
NCT04460456 2022-06-30A Study of SBT6050 Alone and in Combination With PD-1 Inhibitors in Subjects With Advanced HER2 Expressing Solid TumorsSilverback TherapeuticsPhase 1 Unknown58 enrolled